These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34365491)

  • 1. Negative consequences of novel psychoactive substances use among the Polish users.
    Wieczorek Ł; Bujalski M; Dąbrowska K
    Psychiatr Pol; 2021 Apr; 55(2):447-469. PubMed ID: 34365491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motives for using new psychoactive substances in three groups of Polish users: nightlife, marginalised and active on the In.
    Wieczorek Ł; Dąbrowska K; Bujalski M
    Psychiatr Pol; 2022 Jun; 56(3):453-470. PubMed ID: 36342979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.
    Van Hout MC; Benschop A; Bujalski M; Dąbrowska K; Demetrovics Z; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Korf D; Silva JP; Wieczorek Ł; Werse B
    Int J Ment Health Addict; 2018; 16(2):480-495. PubMed ID: 29674947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
    Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
    Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New psychoactive substances and their prevalence in the Czech Republic].
    Mravčík V; Běláčková V; Grohmannová K; Zábranský T
    Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary.
    Csák R; Szécsi J; Kassai S; Márványkövi F; Rácz J
    Int J Drug Policy; 2020 Nov; 85():102639. PubMed ID: 31911024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New psychoactive substances in emergency medicine].
    Marinowitz R; Strube J; Schaper A
    Nervenarzt; 2024 Jan; 95(1):28-34. PubMed ID: 38189941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.
    Benschop A; Urbán R; Kapitány-Fövény M; Van Hout MC; Dąbrowska K; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Silva JP; Wieczorek Ł; Werse B; Bujalski M; Korf D; Demetrovics Z
    J Psychopharmacol; 2020 Jun; 34(6):600-611. PubMed ID: 32043399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M
    Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia.
    Anderson C; Morrell C; Marchevsky D
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoactive substances use experience and addiction or risk of addiction among by Polish adolescents living in rural and urban areas.
    Pawłowska B; Zygo M; Potembska E; Kapka-Skrzypczak L; Dreher P; Kędzierski Z
    Ann Agric Environ Med; 2014; 21(4):776-82. PubMed ID: 25528919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France.
    Batisse A; Leger S; Vicaut E; Gerbaud L; Djezzar S
    Public Health; 2021 May; 194():75-78. PubMed ID: 33865150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel psychoactive drug use among younger adults involved in US nightlife scenes.
    Kelly BC; Wells BE; Pawson M; Leclair A; Parsons JT; Golub SA
    Drug Alcohol Rev; 2013 Nov; 32(6):588-93. PubMed ID: 23795887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.